以重点监控药品管理促进合理用药水平提升  

Promoting the Level of Rational Drug Use by Key Monitoring Drug Management

作　　者：郭振军 左燕[1] 廉江平[1] 周楠[1] 李茁[1] 朱亚宁[1] 张鹏[2] GUO Zhenjun;ZUO Yan;LIAN Jiangping(Shaanxi Provincial People's Hospital,Xi'an,Shaanxi,710068,China;不详)

机构地区：[1]陕西省人民医院,陕西西安710068 [2]陕西省人民医院药学部,陕西西安710068

出　　处：《中国卫生质量管理》2022年第9期68-71,共4页Chinese Health Quality Management

基　　金：陕西省科协技术协会项目(2021PSL120)。

摘　　要：通过开展以“合理用药”为核心的重点监控药品管理,促进合理用药水平提升。采取事后处方点评及处方前置审核,建立和完善重点监控药品管理方案,对不合理用药进行拦截、宣教、绩效处罚、限量采购、约谈等,实现了重点监控药品规范化管理。实践后,不合理医嘱减少,处方点评合格率提升,辅助用药种类减少。认为建立重点监控药品管理的相关制度及流程,对提升合理用药水平有一定促进作用。By managing the key monitoring drugs focus on rational drug use,the level of rational drug use was promoted.A tertiary hospital adopted postevent prescription review and pre-prescription checking,established and improved the methods of key monitoring drug management,managed ir rational drug use issues,such as interception,education,performance penalties,limited purchases and interviews,etc.The standardized management of the rational use of key monitoring drugs had been realized.After practice,the number of irrational medical orders,the types of adjuvant drugs decreased,and the pass rate of prescription reviews increased.The establishmeht of systems and procedures for the key monitoring drug management will have a certain role in promoting the rational use of drugs.

关 键 词：重点监控药品 处方点评 处方前置审核 合理用药 

分 类 号：R197.323[医药卫生—卫生事业管理] R95[医药卫生—公共卫生与预防医学]